“New treatments for mantle cell lymphoma (MCL) have improved survival and increased the life expectancy of survivors,” says Ingrid Glimelius, MD, PhD. “However, due to patients with MCL living longer, late effects have become a...
Read More
For fit patients with chronic lymphocytic leukemia (CLL), venetoclax-obinutuzumab with or without...
Read More
For children receiving maintenance treatment for acute lymphoblastic leukemia (ALL), those living...
Read MoreFor a recent PW podcast episode, Matthias Stelljes, MD, of the Department of Medicine-Hematology and Oncology, University of Muenster, spoke about the randomized Phase 3 ASAP Trial for the management of relapsed/refractory acute...
Read More
There is no question that healthcare and the practice of medicine is becoming increasingly...
Read More
